VERACYTE, INC. - VCYT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Chief Financial Officer | A | A | 13,157.0 | 0.0 | 0.0 | 180,534.0 | View | |
| Mar 10, 2026 | Chief Financial Officer | A | A | 36,181.0 | 0.0 | 0.0 | 167,377.0 | View | |
| Mar 10, 2026 | Chief Executive Officer | A | A | 92,099.0 | 0.0 | 0.0 | 449,653.0 | View | |
| Mar 10, 2026 | VP, Chief Accounting Officer | A | A | 10,525.0 | 0.0 | 0.0 | 45,434.0 | View | |
| Mar 10, 2026 | Chief Commercial Officer-CLIA | A | A | 6,578.0 | 0.0 | 0.0 | 150,339.0 | View | |
| Mar 10, 2026 | Chief Commercial Officer-CLIA | A | A | 36,181.0 | 0.0 | 0.0 | 143,761.0 | View | |
| Mar 10, 2026 | Chief Scientific & Med Officer | A | A | 6,578.0 | 0.0 | 0.0 | 153,527.0 | View | |
| Mar 10, 2026 | Chief Scientific & Med Officer | A | A | 29,603.0 | 0.0 | 0.0 | 146,949.0 | View | |
| Mar 10, 2026 | SVP, General Counsel | A | A | 26,314.0 | 0.0 | 0.0 | 153,912.0 | View | |
| Mar 10, 2026 | SVP, General Counsel | A | A | 32,892.0 | 0.0 | 0.0 | 127,598.0 | View | |
| Mar 06, 2026 | Chief Financial Officer | S | D | 13,941.0 | 36.3288 | 506,459.8 | 131,196.0 | View | |
| Mar 06, 2026 | Chief Financial Officer | S | D | 4,400.0 | 35.5476 | 156,409.44 | 145,137.0 | View | |
| Mar 06, 2026 | SVP, General Counsel | S | D | 1,664.0 | 36.3393 | 60,468.6 | 94,706.0 | View | |
| Mar 06, 2026 | SVP, General Counsel | S | D | 4,994.0 | 35.2936 | 176,256.24 | 96,370.0 | View | |
| Mar 06, 2026 | Chief Commercial Officer-CLIA | S | D | 5,260.0 | 35.1868 | 185,082.57 | 107,580.0 | View | |
| Mar 06, 2026 | Chief Executive Officer | S | D | 26,279.0 | 36.2787 | 953,367.96 | 357,554.0 | View | |
| Mar 06, 2026 | Chief Executive Officer | S | D | 19,244.0 | 35.5553 | 684,226.19 | 383,833.0 | View | |
| Mar 04, 2026 | Chief Scientific & Med Officer | S | D | 13,425.0 | 36.1586 | 485,429.21 | 117,346.0 | View | |
| Mar 04, 2026 | Chief Scientific & Med Officer | F | D | 6,035.0 | 36.01 | 217,320.35 | 130,771.0 | View | |
| Mar 04, 2026 | Chief Commercial Officer-CLIA | F | D | 7,517.0 | 36.01 | 270,687.17 | 112,840.0 | View | |
| Mar 04, 2026 | Chief Financial Officer | F | D | 7,234.0 | 36.01 | 260,496.34 | 149,537.0 | View | |
| Mar 04, 2026 | VP, Chief Accounting Officer | F | D | 3,006.0 | 36.01 | 108,246.06 | 34,909.0 | View | |
| Mar 04, 2026 | SVP, General Counsel | F | D | 6,902.0 | 36.01 | 248,541.02 | 101,364.0 | View | |
| Mar 04, 2026 | Chief Executive Officer | F | D | 19,455.0 | 36.01 | 700,574.55 | 403,077.0 | View | |
| Mar 02, 2026 | SVP, General Counsel | F | D | 10,867.0 | 38.75 | 421,096.25 | 108,266.0 | View | |
| Mar 02, 2026 | SVP, General Counsel | A | A | 50,999.0 | 0.0 | 0.0 | 119,133.0 | View | |
| Mar 02, 2026 | Chief Scientific & Med Officer | F | D | 24,486.0 | 38.75 | 948,832.5 | 136,806.0 | View | |
| Mar 02, 2026 | Chief Scientific & Med Officer | A | A | 71,806.0 | 0.0 | 0.0 | 161,292.0 | View | |
| Mar 02, 2026 | Chief Financial Officer | F | D | 12,049.0 | 38.75 | 466,898.75 | 156,771.0 | View | |
| Mar 02, 2026 | Chief Financial Officer | A | A | 59,324.0 | 0.0 | 0.0 | 168,820.0 | View | |
| Mar 02, 2026 | Chief Executive Officer | F | D | 35,841.0 | 38.75 | 1,388,838.75 | 422,532.0 | View | |
| Mar 02, 2026 | Chief Executive Officer | A | A | 139,074.0 | 0.0 | 0.0 | 458,373.0 | View | |
| Mar 02, 2026 | Chief Commercial Officer-CLIA | F | D | 8,905.0 | 38.75 | 345,068.75 | 120,357.0 | View | |
| Mar 02, 2026 | Chief Commercial Officer-CLIA | A | A | 47,149.0 | 0.0 | 0.0 | 129,262.0 | View | |
| Dec 17, 2025 | SVP, General Counsel | S | D | 100.0 | 43.68 | 4,368.0 | 67,760.0 | View | |
| Dec 17, 2025 | SVP, General Counsel | S | D | 10,639.0 | 43.1277 | 458,835.6 | 67,860.0 | View | |
| Dec 08, 2025 | — | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 08, 2025 | — | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 08, 2025 | — | S | D | 800.0 | 46.5898 | 37,271.84 | 13,554.0 | View | |
| Dec 08, 2025 | — | S | D | 12,808.0 | 45.837 | 587,080.3 | 14,354.0 | View | |
| Dec 08, 2025 | — | S | D | 6,392.0 | 44.5199 | 284,571.2 | 27,162.0 | View | |
| Dec 08, 2025 | — | M | A | 10,000.0 | 7.6 | 76,000.0 | 33,554.0 | View | |
| Dec 08, 2025 | — | M | A | 10,000.0 | 7.94 | 79,400.0 | 23,554.0 | View | |
| Dec 04, 2025 | SVP, General Counsel | S | D | 702.0 | 47.51 | 33,352.02 | 78,499.0 | View | |
| Dec 04, 2025 | SVP, General Counsel | S | D | 720.0 | 47.0955 | 33,908.76 | 79,201.0 | View | |
| Dec 04, 2025 | SVP, General Counsel | F | D | 3,052.0 | 46.16 | 140,880.32 | 79,921.0 | View | |
| Dec 04, 2025 | Chief Commercial Officer-CLIA | S | D | 1,278.0 | 47.51 | 60,717.78 | 82,113.0 | View | |
| Dec 04, 2025 | Chief Commercial Officer-CLIA | F | D | 2,900.0 | 46.16 | 133,864.0 | 83,391.0 | View | |
| Dec 04, 2025 | VP, Chief Accounting Officer | F | D | 1,325.0 | 46.16 | 61,162.0 | 37,420.0 | View | |
| Dec 04, 2025 | Chief Scientific & Med Officer | F | D | 2,955.0 | 46.16 | 136,402.8 | 89,486.0 | View | |
| Dec 04, 2025 | Chief Executive Officer | S | D | 3,220.0 | 47.3485 | 152,462.17 | 318,603.0 | View | |
| Dec 04, 2025 | Chief Executive Officer | S | D | 4,448.0 | 46.9005 | 208,613.42 | 321,823.0 | View | |
| Dec 04, 2025 | Chief Executive Officer | F | D | 7,914.0 | 46.16 | 365,310.24 | 326,271.0 | View | |
| Dec 04, 2025 | Chief Financial Officer | S | D | 4,741.0 | 47.2493 | 224,008.93 | 109,496.0 | View | |
| Dec 04, 2025 | Chief Financial Officer | S | D | 8,537.0 | 46.6143 | 397,946.28 | 114,237.0 | View | |
| Dec 04, 2025 | Chief Financial Officer | F | D | 3,384.0 | 46.16 | 156,205.44 | 122,774.0 | View | |
| Nov 26, 2025 | Chief Commercial Officer-CLIA | S | D | 2,808.0 | 50.0 | 140,400.0 | 86,291.0 | View | |
| Nov 26, 2025 | — | S | D | 1,106.0 | 50.2493 | 55,575.73 | 29,362.0 | View | |
| Nov 21, 2025 | — | S | D | 1,460.0 | 43.2095 | 63,085.87 | 27,199.0 | View | |
| Nov 21, 2025 | — | S | D | 7,049.0 | 42.4765 | 299,416.85 | 28,659.0 | View | |
| Nov 21, 2025 | — | S | D | 1,491.0 | 40.9526 | 61,060.33 | 35,708.0 | View | |
| Nov 12, 2025 | VP, Chief Accounting Officer | S | D | 5,102.0 | 42.3321 | 215,978.37 | 38,745.0 | View | |
| Nov 12, 2025 | VP, Chief Accounting Officer | S | D | 5,818.0 | 40.2078 | 233,928.98 | 43,847.0 | View | |
| Nov 07, 2025 | Chief Financial Officer | S | D | 7,000.0 | 41.0 | 287,000.0 | 126,158.0 | View | |
| Nov 07, 2025 | — | S | D | 9,674.0 | 40.0239 | 387,191.21 | 13,554.0 | View | |
| Nov 07, 2025 | — | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | — | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | — | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | — | S | D | 657.0 | 46.3756 | 30,468.77 | 30,468.0 | View | |
| Nov 07, 2025 | — | S | D | 24,296.0 | 45.7273 | 1,110,990.48 | 31,125.0 | View | |
| Nov 07, 2025 | — | S | D | 5,872.0 | 45.0682 | 264,640.47 | 55,421.0 | View | |
| Nov 07, 2025 | — | S | D | 10,837.0 | 43.8038 | 474,701.78 | 61,293.0 | View | |
| Nov 07, 2025 | — | S | D | 1,126.0 | 43.0329 | 48,455.05 | 72,130.0 | View | |
| Nov 07, 2025 | — | S | D | 408.0 | 41.7431 | 17,031.18 | 73,256.0 | View | |
| Nov 07, 2025 | — | M | A | 10,000.0 | 7.6 | 76,000.0 | 73,664.0 | View | |
| Nov 07, 2025 | — | M | A | 10,000.0 | 7.94 | 79,400.0 | 63,664.0 | View | |
| Nov 07, 2025 | — | M | A | 10,000.0 | 5.28 | 52,800.0 | 53,664.0 | View | |
| Nov 07, 2025 | SVP, General Counsel | S | D | 6,466.0 | 40.0 | 258,640.0 | 82,973.0 | View | |
| Oct 30, 2025 | VP, Chief Accounting Officer | A | A | 2,886.0 | 0.0 | 0.0 | 49,665.0 | View |